Auburndale, MA, United States of America

Robert C Blanks

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

Flexion Therapeutics, Inc.

patents

2 out of 15

Napo Pharmaceuticals, Inc.

patents

Years Active: 2014-2020

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10624905 - Corticosteroids for the treatment of joint pain (2020-04-21),

2. 9980938 - Method for treatment of diarrhea-predominant irritable bowel syndrome (2018-05-29),

3. 9949987 - Corticosteroids for the treatment of joint pain (2018-04-24),

4. 9919006 - Compositions and methods for treating hyperkalemia (2018-03-20),

5. 9867848 - Compositions and methods for treating hyperkalemia (2018-01-16),

6. 9655921 - Compositions and methods for treating hyperkalemia (2017-05-23),

7. 9555048 - Corticosteroids for the treatment of joint pain (2017-01-31),

8. 9555047 - Corticosteroids for the treatment of joint pain (2017-01-31),

9. 9549947 - Pharmaceutical compositions for treating hyperkalemia (2017-01-24),

10. 9545425 - Pharmaceutical compositions for treating hyperkalemia (2017-01-17),

11. 9433640 - Compositions and methods for treating hyperkalemia (2016-09-06),

12. 8846113 - Method for treatment of diarrhea-predominant irritable bowel syndrome (2014-09-30),

13. 8828440 - Corticosteroids for the treatment of joint pain (2014-09-09),

Title: The Innovative Contributions of Robert C. Blanks

Introduction

Robert C. Blanks is a notable inventor based in Auburndale, MA (US), recognized for his significant contributions to the field of medicine. With a total of 13 patents to his name, Blanks has focused on developing innovative treatments for various health conditions, particularly those related to inflammatory diseases and gastrointestinal disorders.

Latest Patents

Among his latest patents, Blanks has developed corticosteroid microparticle formulations aimed at treating joint pain. These formulations are designed to address pain caused by inflammatory diseases such as osteoarthritis and rheumatoid arthritis. The sustained release dosage form of these microparticles ensures efficacy while minimizing any measurable impact on endogenous cortisol production. Another significant patent involves a method for treating diarrhea-predominant irritable bowel syndrome (d-IBS). This invention provides a treatment approach that includes administering an inhibitor of chloride-ion transport, specifically crofelemer, to alleviate the symptoms associated with d-IBS.

Career Highlights

Throughout his career, Robert C. Blanks has worked with prominent companies in the pharmaceutical industry, including Ardelyx, Inc. and Flexion Therapeutics, Inc. His work has contributed to advancements in medical treatments that improve patient outcomes and quality of life.

Collaborations

Blanks has collaborated with esteemed colleagues such as Dominique Charmot and James Prentice Davidson, further enhancing the impact of his innovative work in the medical field.

Conclusion

Robert C. Blanks exemplifies the spirit of innovation through his dedicated work in developing effective treatments for complex health issues. His contributions continue to influence the medical community and improve the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.